Interestingly, the identification of EZH2 mutations was correlated, in most cases, with the loss of EZH2 protein expression, as evaluated by immunohistochemical analysis, thus directly linking the sequencing data to the AML phenotype [21]. The gene discussed is EZH2; the disease is acute myeloid leukemia.